Daniel O’Mahony is a Partner at Seroba Life Sciences venture capital fund and brings a wealth of experience from pharma and medtech industry in product development, strategic planning, licensing, corporate venturing, technology commercialisation and venture capital investment. Daniel graduated with a Ph.D. from University College Cork, holds a business degree in technology management from the Smurfit Business School and has held academic appointments in Ireland and USA. He currently sits on a number of boards include Atlantic Therapeutics, Perfuze and ATXA Therapeutics.  He previously sat on the boards of PQ Bypass (acquired by Endologix), Novate Medical (acquired by BTG), Apica Cardiovascular (acquired by Thoratec), Covagen (acquired by Janssen), Stokes Bio (acquired by Life Technologies), Straatum (acquired by Lam Research Corporation).